Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss

Medicines in development in 2009 for bladder cancer (InTextoResearch)

0 views
Skip to first unread message

SciMedWeb

unread,
Dec 16, 2009, 5:47:31 AM12/16/09
to
Medicines in development in 2009 for bladder cancer:


● Advexin (contusugene ladenovec) Phase I
● BC-819 Phase II
● belinostat Phase II
● CDX-1307 Phase I
● Celebrex (celecoxib) Phase III
● CG0070 Phase I
● Chemophase (hyluronidase) Phase I/II
● EOquin (apaziquone) Phase III
● Erbitux (cetuximab) Phase II
● Hexvix (hexyl aminolevulinate)
● Iressa® (gefitinib) Phase II
● larotaxel (XRP9881) Phase III
● Levulan (aminolevulinic acid) Phase I/II
● MCC/HA Phase III
● OGX-427 Phase I
● polyphenon E Phase II
● pralatrexate (PDX) Phase II
● SCH-58500 (p53 gene therapy) Phase I
● SCH-721015 Phase I
● Tarceva (erlotinib) Phase II
● Valstar (valrubicin)
● VB-4845 Phase II
● vinflunine Phase II

InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scim...@mail.com)

0 new messages